Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1988 Oct;60(4):275–280. doi: 10.1136/hrt.60.4.275

Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker.

K J Hogg 1, R S Hornung 1, C A Howie 1, N Hockings 1, F G Dunn 1, W S Hillis 1
PMCID: PMC1216573  PMID: 3190955

Abstract

The predictive value of the measurement of changes in ST segment elevation was assessed as a non-invasive marker of coronary artery reperfusion after thrombolytic treatment. Forty five patients with acute myocardial infarction (23 anterior, 22 inferior) of less than six hours' duration were given thrombolytic treatment by either the intravenous (n = 28) or the intracoronary route (n = 17). A proportional value for the shift in ST segment, termed the fractional change, was calculated both from 12 lead electrocardiograms and from the Holter tape for each patient. Coronary artery patency in an initial group of 22 patients (training group) was associated with a fractional change value of greater than or equal to 0.5 (100% specific, 88% sensitive by Holter analysis; 100% specific, 94% sensitive by 12 lead electrocardiogram). This rule performed well when it was applied to a test group of 17 patients (100% specific, 93% sensitive by Holter analysis; and 67% specific, 93% sensitive by 12 lead electrocardiogram). Linear discriminant analysis was then used to determine which features gave the best separation of those in whom there was reperfusion and those in whom there was not. This gave 100% specificity and 100% sensitivity when applied to the training group for either the 12 lead electrocardiogram or Holter monitoring. When it was applied to the test group, the sensitivity was maintained at 100%, but the specificity dropped to 33% irrespective of whether the basis of the test was Holter monitoring or the 12 lead electrocardiogram. These results suggest that a fractional change of >/= 0.5 calculated from a single lead showing myocardial injury is a useful non-invasive marker of reperfusion. The technique can be applied to either 12 lead electrocardiograms or Holter monitoring. The use of a more complex classification increased the sensitivity of the test at the expense of its specificity.

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Marshall H. W., Askins J. C., Lutz J. R., Sorensen S. G., Menlove R. L., Yanowitz F. G., Hagan A. D. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation. 1984 Oct;70(4):606–618. doi: 10.1161/01.cir.70.4.606. [DOI] [PubMed] [Google Scholar]
  2. Been M., de Bono D. P., Muir A. L., Boulton F. E., Hillis W. S., Hornung R. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J. 1985 Mar;53(3):253–259. doi: 10.1136/hrt.53.3.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gold H. K., Leinbach R. C., Maroko P. R. Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. Am J Cardiol. 1976 Nov 23;38(6):689–695. doi: 10.1016/0002-9149(76)90344-1. [DOI] [PubMed] [Google Scholar]
  4. Hillis W. S., Jones C. R., Been M., Campbell B. C., Fulton W. F. Intracoronary thrombolytic therapy performed within a coronary care unit: one year's experience. Scott Med J. 1986 Jan;31(1):25–29. doi: 10.1177/003693308603100106. [DOI] [PubMed] [Google Scholar]
  5. Kennedy J. W., Ritchie J. L., Davis K. B., Stadius M. L., Maynard C., Fritz J. K. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. N Engl J Med. 1985 Apr 25;312(17):1073–1078. doi: 10.1056/NEJM198504253121701. [DOI] [PubMed] [Google Scholar]
  6. LEVINE H. D., WANZER S. H., MERRILL J. P. Dialyzable currents of injury in potassium intoxication resembling acute myocardial infarction or pericarditis. Circulation. 1956 Jan;13(1):29–36. doi: 10.1161/01.cir.13.1.29. [DOI] [PubMed] [Google Scholar]
  7. Leinbach R. C., Gold H. K., Harper R. W., Buckley M. J., Austen W. G. Early intraaortic balloon pumping for anterior myocardial infarction without shock. Circulation. 1978 Aug;58(2):204–210. doi: 10.1161/01.cir.58.2.204. [DOI] [PubMed] [Google Scholar]
  8. Madias J. E., Venkataraman K., Hodd W. B., Jr Precordial ST-segment mapping 1. Clinical studies in the coronary care unit. Circulation. 1975 Nov;52(5):799–809. doi: 10.1161/01.cir.52.5.799. [DOI] [PubMed] [Google Scholar]
  9. Maroko P. R., Hillis L. D., Muller J. E., Tavazzi L., Heyndrickx G. R., Ray M., Chiariello M., Distante A., Askenazi J., Salerno J. Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med. 1977 Apr 21;296(16):898–903. doi: 10.1056/NEJM197704212961603. [DOI] [PubMed] [Google Scholar]
  10. Muller J. E., Maroko P. R., Braunwald E. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation. 1975 Jul;52(1):16–27. doi: 10.1161/01.cir.52.1.16. [DOI] [PubMed] [Google Scholar]
  11. SODI-PALLARES D., CISNEROS F., MEDRANO G. A., BISTENI A., TESTELLI M. R., DEMICHELI A. ELECTROCARDIOGRAPHIC DIAGNOSIS OF MYOCARDIAL INFARCTION IN THE PRESENCE OF BUNDLE BRANCH BLOCK (RIGHT AND LEFT), VENTRICULAR PREMATURE BEATS AND WOLFF-PARKINSON-WHITE SYNDROME. Prog Cardiovasc Dis. 1963 Sep;6:107–136. doi: 10.1016/s0033-0620(63)80024-9. [DOI] [PubMed] [Google Scholar]
  12. Schröder R., Biamino G., von Leitner E. R., Linderer T., Brüggemann T., Heitz J., Vöhringer H. F., Wegscheider K. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation. 1983 Mar;67(3):536–548. doi: 10.1161/01.cir.67.3.536. [DOI] [PubMed] [Google Scholar]
  13. Thadani U., Chopra M. P., Aber C. P., Portal R. W. Pericarditis after acute myocardial infarction. Br Med J. 1971 Apr 17;2(5754):135–137. doi: 10.1136/bmj.2.5754.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Verstraete M., Bleifeld W., Brower R. W., Charbonnier B., Collen D., de Bono D. P., Dunning A. J., Lennane R. J., Lubsen J., Mathey D. G. Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction. Lancet. 1985 Nov 2;2(8462):965–969. doi: 10.1016/s0140-6736(85)90523-9. [DOI] [PubMed] [Google Scholar]
  15. von Essen R., Schmidt W., Uebis R., Edelmann B., Effert S., Silny J., Rau G. Myocardial infarction and thrombolysis. Electrocardiographic short term and long term results using precordial mapping. Br Heart J. 1985 Jul;54(1):6–10. doi: 10.1136/hrt.54.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES